Functional neural correlates of mindfulness meditations in comparison with psychotherapy, pharmacotherapy and placebo effect. Is there a link?

Acta Neuropsychiatrica

Volumn 22, Issue 3, 2010, Pages 104-117

  Chiesa, Alberto ^a   Brambilla, Paolo ^b,c   Serretti, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Mindfulness; Neuroimaging; Pharmacotherapy; Placebo; Psychotherapy

Indexed keywords

AMYGDALOID NUCLEUS; BRAIN FUNCTION; CORRELATION ANALYSIS; EMOTIONALITY; FRONTAL CORTEX; HUMAN; INTERMETHOD COMPARISON; MEDICAL LITERATURE; MEDITATION; NEUROIMAGING; PLACEBO EFFECT; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW;

EID: 77951955146     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2010.00460.x     Document Type: Review

References (134)

1. Taylor E. Introduction. In: Murphy M, Donovan S, Sausalito CA, eds. The physical and physiological effects of meditation. Institute of Noetic Science, 1999.
2. Ospina MB, Bond K, Karkhaneh M et al. Meditation practices for health: state of the research. Evid Rep Technol Assess (Full Rep) 2007 1 263.
3. Barinaga M. Buddhism and neuroscience. Studying the well-trained mind. Science 2003 302 : 44 46.
4. Chiesa A, Serretti A. A systematic review of neurobiological and clinical features of mindfulness meditations. Psychol Med 2009 : 1 14.
5. Kabat-Zinn J. Wherever you go, there you are: mindfulness meditation in everyday life.
6. Marlatt GA, Kristeller JL. Integrating spirituality into treatment: resources for practitioners. In: Miller WR, ed. Mindfulness and meditation.
7. Buddhaghosa B. Vissuddhimagga (The Path of Purification).
8. Kabat-Zinn J. Indra's net at work: the mainstreaming of Dharma practice in society.
9. Ahir DC. Vipassana: a universal Buddhist meditation technique.
10. Mizuno K. Essentials of Buddhism.
11. Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain and illness.
12. Segal ZJ, Williams MG, Teasdale JD. Mindfulness based cognitive therapy for depression: a new approach to preventing relapses.
13. Bishop SR. What do we really know about mindfulness-based stress reduction? Psychosom Med 2002 64 : 71 83. (Pubitemid 34137401)
14. Proulx K. Integrating mindfulness-based stress reduction. Holist Nurs Pract 2003 17 : 201 208.
15. Allen NB, Chambers R, Knight W. Mindfulness-based psychotherapies: a review of conceptual foundations, empirical evidence and practical considerations. Aust N Z J Psychiatry 2006 40 : 285 294.
16. Chiesa A, Serretti A. Mindfulness-based stress reduction for stress management in healthy people: a review and meta-analysis. J Altern Complement Med 2009 15 : 593 600.
17. Coelho HF, Canter PH, Ernst E. Mindfulness-based cognitive therapy: evaluating current evidence and informing future research. J Consult Clin Psychol 2007 75 : 1000 1005.
18. Chiesa A. Vipassana meditation: systematic review of current evidence. J Altern Complement Med 2010 16 : 37 46.
19. Chiesa A. Zen meditation: an integration of current evidence. J Altern Complement Med 2009 15 : 585 592.
20. Cahn BR, Polich J. Meditation states and traits: EEG, ERP, and neuroimaging studies. Psychol Bull 2006 132 : 180 211. (Pubitemid 43439926)
21. Goleman D. The meditative mind: the varieties of meditative experience.
22. Rubia K. The neurobiology of Meditation and its clinical effectiveness in psychiatric disorders. Biol Psychol 2009 1 : 1 11.
23. Dougherty DD, Rauch SL, Rosenbaum JF. Essentials of neuroimaging for clinical practice.
24. Giove F, Mangia S, Bianciardi M et al. The physiology and metabolism of neuronal activation: in vivo studies by NMR and other methods. Magn Reson Imaging 2003 21 : 1283 1293. (Pubitemid 38199732)
25. Price DD, Finniss DG, Benedetti F. A Comprehensive Review of the placebo effect: recent advances and current thought. Annu Rev Psychol 2008 59 : 565 590.
26. Faria V, Fredrikson M, Furmark T. Imaging the placebo response: a neurofunctional review. Eur Neuropsychopharmacol 2008 18 : 473 485.
27. Rupke SJ, Blecke D, Renfrow M. Cognitive therapy for depression. Am Fam Physician 2006 73 : 83 86. (Pubitemid 43161247)
28. Derubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci 2008 9 : 788 796.
29. Otto MW, Deveney C. Cognitive-behavioral therapy and the treatment of panic disorder: efficacy and strategies. J Clin Psychiatry 2005 66 (Suppl. 4 28 32. (Pubitemid 40637723)
30. Rowa K, Antony MM. Psychological treatments for social phobia. Can J Psychiatry 2005 50 : 308 316. (Pubitemid 43175508)
31. Jonsson H, Hougaard E. Group cognitive behavioural therapy for obsessive-compulsive disorder: a systematic review and meta-analysis. Acta Psychiatr Scand 2009 119 : 98 106.
32. Choy Y, Fyer AJ, Lipsitz JD. Treatment of specific phobia in adults. Clin Psychol Rev 2007 27 : 266 286. (Pubitemid 46329869)
33. De Mello MF, De Jesus Mari J, Bacaltchuk J, Verdeli H, Neugebauer R. A systematic review of research findings on the efficacy of interpersonal therapy for depressive disorders. Eur Arch Psychiatry Clin Neurosci 2005 255 : 75 82. (Pubitemid 40575662)
34. Shepherd J, Stein K, Milne R. Eye movement desensitization and reprocessing in the treatment of post-traumatic stress disorder: a review of an emerging therapy. Psychol Med 2000 30 : 863 871. (Pubitemid 30623972)
35. Cipriani A, Furukawa TA, Salanti G et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009 373 : 746 758.
36. Zohar J, Westenberg HG. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 2000 403 : 39 49.
37. Benedetti F. Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol 2008 48 : 33 60. (Pubitemid 351738148)
38. Pollo A, Benedetti F. Placebo response: Relevance to the rheumatic diseases. Rheum Dis Clin North Am 2008 34 : 331 349. (Pubitemid 351970202)
39. Baerentsen KB, Hartvig NV, Stodkilde-Jorgensen H, Mammen J. Onset of meditation explored with fMRI. Neuroimage 2001 13 : 297.
40. Holzel BK, Ott U, Hempel H et al. Differential engagement of anterior cingulate and adjacent medial frontal cortex in adept meditators and non-meditators. Neurosci Lett 2007 421 : 16 21. (Pubitemid 46899325)
41. Farb NAS, Segal ZV, Mayberg HS et al. Attending to the present: mindfulness meditation reveals distinct neural modes of self reference. Soc Cogn Affect Neurosci 2007 2 : 313 322.
42. Kozasa EH, Radvany J, Barreiros MA, Leite JR, Amaro E. Preliminary functional magnetic resonance imaging Stroop task results before and after a Zen meditation retreat. Psychiatry Clin Neurosci 2008 62 : 366. (Pubitemid 351832317)
43. Pagnoni G, Cekic M, Guo Y. "Thinking about Not-Thinking": neural correlates of conceptual processing during zen meditation. PLoS Med 2008 3 : e383 e392.
44. Brody AL, Saxena S, Silverman DH et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res 1999 91 : 127 139. (Pubitemid 29474048)
45. Mayberg HS, Brannan SK, Tekell JL et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000 48 : 830 843.
46. Kennedy SH, Evans KR, Kruger S et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 2001 158 : 899 905. (Pubitemid 32547619)
47. Brody AL, Saxena S, Stoessel P et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001a 58 : 631 640. (Pubitemid 32640857)
48. Brody AL, Saxena S, Mandelkern MA, Fairbanks LA, Ho ML, Baxter LR. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiatry 2001b 50 : 171 178. (Pubitemid 32763094)
49. Davidson RJ, Irwin W, Anderle MJ, Kalin NH. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003 160 : 64 75. (Pubitemid 36042428)
50. Fu CH, Williams SC, Cleare AJ et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 2004 61 : 877 889.
51. Goldapple K, Segal Z, Garson C et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 2004 61 : 34 41. (Pubitemid 38044639)
52. Anand A, Li Y, Wang Y et al. Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study. Neuropsychopharmacology 2005 30 : 1334 1344. (Pubitemid 40848087)
53. Chen CH, Ridler K, Suckling J et al. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry 2007 62 : 407 414. (Pubitemid 47284016)
54. Kennedy SH, Konarski JZ, Segal ZV et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry 2007 164 : 778 788.
55. Fu CH, Williams SC, Cleare AJ et al. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry 2008 64 : 505 512.
56. Furmark T, Tillfors M, Marteinsdottir I et al. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry 2002 59 : 425 433. (Pubitemid 34477677)
57. Paquette V, Levesque J, Mensour B et al. "Change the mind and you change the brain": effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage 2003 18 : 401 409. (Pubitemid 36269149)
58. Straube T, Glauer M, Dilger S, Mentzel HJ, Miltner WH. Effects of cognitive-behavioral therapy on brain activation in specific phobia. Neuroimage 2006 29 : 125 135. (Pubitemid 41828037)
59. Goossens L, Sunaert S, Peeters R, Griez EJ, Schruers KR. Amygdala hyperfunction in phobic fear normalizes after exposure. Biol Psychiatry 2007 62 : 1119 1125. (Pubitemid 350029725)
60. Schienle A, Schafer A, Hermann A, Rohrmann S, Vaitl D. Symptom provocation and reduction in patients suffering from spider phobia: an fMRI study on exposure therapy. Eur Arch Psychiatry Clin Neurosci 2007 257 : 486 493. (Pubitemid 351208373)
61. Prasko J, Horacek J, Zalesky R et al. The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol Lett 2004 25 : 340 348. (Pubitemid 39625042)
62. Lindauer RJ, Gersons BP, Van Meijel EP et al. Effects of brief eclectic psychotherapy in patients with posttraumatic stress disorder: randomized clinical trial. J Trauma Stress 2005 18 : 205 212.
63. Lansing K, Amen DG, Hanks C, Rudy L. High-resolution brain SPECT imaging and eye movement desensitization and reprocessing in police officers with PTSD. J Neuropsychiatry Clin Neurosci 2005 17 : 526 532. (Pubitemid 41790054)
64. Pagani M, Hogberg G, Salmaso D et al. Effects of EMDR psychotherapy on 99mTc-HMPAO distribution in occupation-related post-traumatic stress disorder. Nucl Med Commun 2007 28 : 757 765. (Pubitemid 47345706)
65. Felmingham K, Kemp A, Williams L et al. Changes in anterior cingulate and amygdala after cognitive behavior therapy of posttraumatic stress disorder. Psychol Sci 2007 18 : 127 129.
66. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia - imaging a shared neuronal network. Science 2002 295 : 1737 1740. (Pubitemid 34202913)
67. Wager TD, Rilling JK, Smith EE et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004 303 : 1162 1167.
68. Petrovic P, Dietrich T, Fransson P, Andersson J, Carlsson K, Ingvar M. Placebo in emotional processing - induced expectations of anxiety relief activate a generalized modulatory network. Neuron 2005 46 : 957 969. (Pubitemid 40805354)
69. Zubieta JK, Bueller JA, Jackson LR et al. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 2005 25 : 7754 7762.
70. Zubieta JK, Yau WY, Scott DJ, Stohler CS. Belief or Need? Accounting for individual variations in the neurochemistry of the placebo effect. Brain Behav Immun 2006 20 : 15 26.
71. Pariente J, White P, Frackowiak RS, Lewith G. Expectancy and belief modulate the neuronal substrates of pain treated by acupuncture. Neuroimage 2005 25 : 1161 1167. (Pubitemid 40591656)
72. Kong J, Gollub RL, Rosman IS et al. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci 2006 26 : 381 388. (Pubitemid 43237100)
73. Bingel U, Lorenz J, Schoell E, Weiller C, Buchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 2006 120 : 8 15. (Pubitemid 43078587)
74. Nemoto M, Mito T, Brinigar WS, Fronticelli C, Koehler RC. Salvage of focal cerebral ischemic damage by transfusion of high O2-affinity recombinant hemoglobin polymers in mouse. J Appl Physiol 2006 100 : 1688 1691.
75. Wager TD, Scott DJ, Zubieta JK. Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A 2007 104 : 11056 11061.
76. Lieberman MD, Jarcho JM, Berman S et al. The neural correlates of placebo effects: a disruption account. Neuroimage 2004 22 : 447 455. (Pubitemid 38515854)
77. Price DD, Craggs J, Verne GN, Perlstein WM, Robinson ME. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 2007 127 : 63 72.
78. Craggs JG, Price DD, Perlstein WM, Nicholas Verne G, Robinson ME. The dynamic mechanisms of placebo induced analgesia: evidence of sustained and transient regional involvement. Pain 2008 139 : 660 669.
79. Mayberg HS, Silva JA, Brannan SK et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002 159 : 728 737.
80. Furmark T, Appel L, Henningsson S et al. A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci 2008 28 : 13066 13074.
81. Newberg AB, Iversen J. The neural basis of the complex mental task of meditation: neurotransmitter and neurochemical considerations. Med Hypotheses 2003 61 : 282 291. (Pubitemid 36976198)
82. Van Veen V, Carter CS. The anterior cingulate as a conflict monitor: fMRI and ERP studies. Physiol Behav 2002 77 : 477 482. (Pubitemid 36084388)
83. Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 2000 4 : 215 222. (Pubitemid 30332147)
84. Phan KL, Wager T, Taylor SF, Liberzon I. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 2002 16 : 331 348. (Pubitemid 34852450)
85. Creswell JD, Way BM, Eisenberger NI, Lieberman MD. Neural correlates of dispositional mindfulness during affect labeling. Psychosom Med 2007 69 : 560 565. (Pubitemid 47205740)
86. Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment 2006 13 : 27 45. (Pubitemid 43812613)
87. Brown KW, Ryan RM. The benefits of being present: mindfulness and its role in psychological well.being. J Pers Soc Psychol 2003 84 : 822 848.
88. Lau MA, Bishop SR, Segal ZV et al. The Toronto mindfulness scale: development and validation. J Clin Psychol 2006 62 : 1445 1467. (Pubitemid 44862639)
89. Cohen-Katz J, Wiley S, Capuano T, Baker D, Shapiro S. The effects of mindfulness based stress reduction on nurse stress and burnout: a qualitative and quantitative study. Holist Nurs Pract 2005 19 : 26 35.
90. Shapiro S, Brown KW, Biegel G. Teaching self-care to care-givers: effects of mindfulness-based stress reduction on the mental health of therapists in training. Train Educ Prof Psychol 2007 1 : 105 115.
91. Carmody J, Reed G, Kristeller J, Merriam P. Mindfulness, spirituality, and health-related symptoms. J Psychosom Res 2008 64 : 393 403.
92. Damasio AR. The feeling of what happens: body and emotion in the making of consciousness.
93. Craig AD. Human feelings: why are some more aware than others? Trends Cogn Sci 2004 8 : 239 241. (Pubitemid 38692510)
94. Panksepp J. Affective consciousness: core emotional feelings in animals and humans. Conscious Cogn 2005 14 : 30 80. (Pubitemid 40342729)
95. Ruby P, Decety J. How would you feel versus how do you think she would feel? A neuroimaging study of perspective-taking with social emotions. J Cogn Neurosci 2004 16 : 988 999. (Pubitemid 38998776)
96. Ochsner KN, Bunge SA, Gross JJ, Gabrieli JD. Rethinking feelings: an FMRI study of the cognitive regulation of emotion. J Cogn Neurosci 2002 14 : 1215 1229.
97. Kalisch R, Wiech K, Critchley HD et al. Anxiety reduction through detachment: subjective, physiological, and neural effects. J Cogn Neurosci 2005 17 : 874 883. (Pubitemid 40800021)
98. Mason MF, Norton MI, Van Horn JD, Wegner DM, Grafton ST, Macrae CN. Wandering minds: the default network and stimulus-independent thought. Science 2007 315 : 393 395.
99. Brosschot JF, Gerin W, Thayer JF. The perseverative cognition hypothesis: a review of worry, prolonged stress-related physiological activation, and health. J Psychosom Res 2006 60 : 113 124. (Pubitemid 43139074)
100. Clayton IC, Richards JC, Edwards CJ. Selective attention in obsessive-compulsive disorder. J Abnorm Psychol 1999 108 : 171 175.
101. Hofmann SG. Cognitivefactors that maintain social anxiety disorder: a comprehensive model and its treatment implications. Cogn Behav Ther 2007 36 : 193 209.
102. Borders A, Barnwell SS, Earleywine M. Alcohol-aggression expectancies and dispositional rumination moderate the effect of alcohol consumption on alcohol-related aggression and hostility. Aggress Behav 2007 33 : 327 338. (Pubitemid 44770101)
103. Teasdale JD, Segal Z, Williams JM. How does cognitive therapy prevent depressive relapse and why should attentional control (mindfulness) training help? Behav Res Ther 1995 33 : 25 39.
104. Siegle GJ, Steinhauer SR, Thase ME, Stenger VA, Carter CS. Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry 2002 51 : 693 707.
105. Kuyken W, Byford S, Taylor RS et al. Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. J Consult Clin Psychol 2008 76 : 966 978.
106. Kabat-Zinn J, Massion AO, Kristeller J et al. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatry 1992 149 : 936 943.
107. Miller JJ, Fletcher K, Kabat-Zinn J. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. Gen Hosp Psychiatry 1995 17 : 192 200.
108. Koszycki D, Benger M, Shlik J, Bradwejn J. Randomized trial of a meditation-based stress reduction program and cognitive behavior therapy in generalized social anxiety disorder. Behav Res Ther 2007 45 : 2518 2526. (Pubitemid 47374085)
109. Fairfax H. The use of mindfulness in obsessive compulsive disorder: suggestions for its application and integration in existing treatment. Clin Psychol Psychother 2008 15 : 53 59. (Pubitemid 351351037)
110. Analayo. Satipatthana: the direct path to realization.
111. Kapleau P. The three pillars of Zen: teaching, practice and enlightenment.
112. Abercrombie HC, Schaefer SM, Larson CL et al. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport 1998 9 : 3301 3307. (Pubitemid 28522352)
113. Drevets WC. Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci 1999 877 : 614 637.
114. Evans KC, Wright CI, Wedig MM, Gold AL, Pollack MH, Rauch SL. A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder. Depress Anxiety 2008 25 : 496 505.
115. Eren I, Tukel R, Polat A, Karaman R, Unal S. Evaluation of regional cerebral blood flow changes in panic disorder with Tc99m-HMPAO SPECT. Psychiatry Res 2003 123 : 135 143. (Pubitemid 36794579)
116. Davidson RJ. Affective style, psychopathology, and resilience: brain mechanisms and plasticity. Am Psychol 2000 55 : 1196 1214.
117. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997 9 : 471 481.
118. Davidson RJ. Affective neuroscience and psychophysiology: toward a synthesis. Psychophysiology 2003 40 : 655 665.
119. Siegle GJ, Thompson W, Carter CS, Steinhauer SR, Thase ME. Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol Psychiatry 2007 61 : 198 209.
120. Bremner JD. Neuroimaging studies in post-traumatic stress disorder. Curr Psychiatry Rep 2002 4 : 254 263.
121. Mayberg HS, Liotti M, Brannan SK et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999 156 : 675 682. (Pubitemid 29220063)
122. Ochsner KN, Ray RD, Cooper JC et al. For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage 2004 23 : 483 499.
123. Ray JP, Price JL. The organization of projections from the mediodorsal nucleus of the thalamus to orbital and medial prefrontal cortex in macaque monkeys. J Comp Neurol 1993 337 : 1 31.
124. Ghashghaei HT, Barbas H. Pathways for emotion: Interactions of prefrontal and anterior temporal pathways in the amygdala of the rhesus monkey. Neuroscience 2002 115 : 1261 1279. (Pubitemid 35351714)
125. Lazar SW, Kerr CE, Wasserman RH et al. Meditation experience is associated with increased cortical thickness. Neuroreport 2005 16 : 1893 1897.
126. Holzel BK, Ott U, Gard T et al. Investigation of mindfulness meditation practitioners woth voxel-based morphometry. Soc Cogn Affect Neurosci 2008 3 : 55 61. (Pubitemid 351790960)
127. Pagnoni G, Cekic M. Age effects on gray matter volume and attentional performance in Zen meditation. Neurobiol Aging 2007 28 : 1623 1627. (Pubitemid 47238540)
128. Recanzone GH, Merzenich MM, Jenkins WM, Grajski KA, Dinse HR. Topographic reorganization of the hand representation in cortical area 3b owl monkeys trained in a frequency-discrimination task. J Neurophysiol 1992 67 : 1031 1056.
129. Bao S, Chang EF, Woods J, Merzenich MM. Temporal plasticity in the primary auditory cortex induced by operant perceptual learning. Nat Neurosci 2004 7 : 974 981. (Pubitemid 39129507)
130. Bangert M, Altenmuller EO. Mapping perception to action in piano practice: a longitudinal DC-EEG study. BMC Neurosci 2003 4 : 26 39. (Pubitemid 38729154)
131. Baer RA. Mindfulness training as a clinical intervention: a conceptual and empirical review. Clin Psychol Sci Pract 2003 10 : 125 143.
132. Linden DE. How psychotherapy changes the brain - the contribution of functional neuroimaging. Mol Psychiatry 2006 11 : 528 538.
133. Roffman JL, Marci CD, Glick DM, Dougherty DD, Rauch SL. Neuroimaging and the functional neuroanatomy of psychotherapy. Psychol Med 2005 35 : 1385 1398.
134. Ivanovski B, Malhi GS. The psychological and neurophysiological concomitants of mindfulness forms of meditation. Acta neuropsychiatrica 2007 19 : 76 91. (Pubitemid 46596159)